Extra-stent vascular remodeling in in-stent restenosis after 188Re-MAG3 radiation therapy

Int J Cardiol. 2003 Dec;92(2-3):187-91. doi: 10.1016/s0167-5273(03)00057-3.

Abstract

Background: The effect of beta-radiation on extra-stent vascular remodeling in patients with in-stent restenosis has not been studied. The correlation between the extent of extra-stent plaque proliferation and that of intimal hyperplasia (IH) in in-stent restenosis in patients who received beta-radiation therapy as well as conventional therapy has also not been studied.

Methods: We evaluated the extra-stent remodeling in diffuse in-stent restenosis between a beta-radiation therapy patient group (188Re-MAG3, n=50) and a control group (n=9) by applying serial intravascular ultrasound (IVUS) analysis. Matching (post-intervention and follow-up) images were acquired at the follow-up lesion site and were available in 44 of 50 patients who received radiation therapy and in seven of nine control patients.

Results: There was a significant increase of the external elastic membrane (EEM) area in both groups: 16.4 +/- 3.3 mm2 post-intervention to 17.1 +/- 3.3 mm2 at follow-up, P=0.001 in the radiation therapy group, and 16.8 +/- 4.0 mm2 post-intervention to 17.4 +/- 4.1 mm2 at follow-up, P=0.008 in the control group. There were no statistically significant differences of the Delta EEM area between the two groups: 0.7 +/- 0.4 mm2 in the radiation therapy group vs. 0.6 +/- 0.4 mm2 in the control group, P=0.389. The Delta IH area correlated with the Delta EEM area in the control group (r=0.826, P=0.022), but not in the radiation therapy group (r=0.016, P=0.919).

Conclusions: The findings of this IVUS study were that positive remodeling (increased EEM area) occurred equally in both control and irradiated patients with in-stent restenosis. The extent of remodeling was directly in proportion to IH in the control group, but no such relationship existed in the irradiated patient group.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Coronary Restenosis / diagnostic imaging
  • Coronary Restenosis / physiopathology
  • Coronary Restenosis / radiotherapy*
  • Follow-Up Studies
  • Humans
  • Hyperplasia
  • Oligopeptides / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Radioisotopes / therapeutic use*
  • Radiopharmaceuticals / therapeutic use*
  • Reproducibility of Results
  • Rhenium / therapeutic use*
  • Stents*
  • Time Factors
  • Tunica Intima / pathology
  • Ultrasonography, Interventional

Substances

  • Oligopeptides
  • Organometallic Compounds
  • Radioisotopes
  • Radiopharmaceuticals
  • rhenium-mercaptoacetyltriglycine
  • Rhenium